106 filings
Page 3 of 6
425
x1lv fzs29agw6
28 Aug 23
Business combination disclosure
7:38am
S-4/A
6ywdsy3 zql9
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
CORRESP
wg04w1cgm
25 Aug 23
Correspondence with SEC
12:00am
SEC STAFF LETTER
vcdp0r 5llb
16 Aug 23
SEC staff letter
12:00am
UPLOAD
nv3drdy5d 8fjtxu4
16 Aug 23
Letter from SEC
12:00am
S-4
0p5krs
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
32gv5jd1m1ntdlizj4w
22 Jun 23
Business combination disclosure
9:12am
8-K
3ww8usodsg698
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
eo0n07ym
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
r4a4 cetko
30 May 23
Talaris Therapeutics Announces Leadership Transition
4:51pm
ARS
kbnz547r stjvzf2x0uw
28 Apr 23
Annual report to shareholders
4:30pm
DEFA14A
jnp 7qefad
28 Apr 23
Additional proxy soliciting materials
4:08pm
8-K
esqnap jycc606xc
14 Apr 23
Cost Associated with Exit or Disposal Activities
5:20pm
S-8
1v1 gb4wkkl85zas8
31 Mar 23
Registration of securities for employees
4:12pm
8-K
7wbpexr91u4zp
10 Mar 23
Regulation FD Disclosure
4:03pm
8-K
e7mo8 i0owklgk3pib
16 Feb 23
Talaris Therapeutics Announces Plans to Explore Strategic Alternatives and Implements Restructuring Plan
7:10am